Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung disease

被引:8
|
作者
Bruni, Cosimo [1 ,2 ]
Occhipinti, Mariaelena [3 ]
Pienn, Michael [4 ]
Camiciottoli, Gianna [5 ,6 ]
Bartolucci, Maurizio [7 ]
Bosello, Silvia Laura [8 ]
Payer, Christian [9 ]
Balint, Zoltan [10 ]
Larici, Anna Rita [11 ,12 ]
Tottoli, Alessandra [1 ]
Tofani, Lorenzo [1 ,13 ]
De Lorenzis, Enrico [8 ]
Lepri, Gemma [1 ]
Bellando-Randone, Silvia [1 ]
Spinella, Amelia [14 ]
Giuggioli, Dilia [14 ]
Masini, Francesco [15 ]
Cuomo, Giovanna [15 ]
Lavorini, Federico [5 ,6 ]
Colagrande, Stefano [16 ]
Olschewski, Horst [4 ,17 ]
Matucci-Cerinic, Marco [1 ,18 ]
机构
[1] Azienda Osped Univ Careggi, Dept Expt & Clin Med, Div Rheumatol, Via Oblate 4, I-50141 Florence, Italy
[2] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland
[3] Radiomics, Liege, Belgium
[4] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria
[5] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy
[6] Careggi Univ Hosp, Dept CardioThoracoVasc, Florence, Italy
[7] Santo Stefano Hosp, Dept Radiol, Prato, Italy
[8] Fdn Policlin Univ A Gemelli IRCCS, Dept Rheumatol, Rome, Italy
[9] Graz Univ Technol, Inst Comp Graph & Vis, Graz, Austria
[10] Babes Bolyai Univ, Fac Phys, Cluj Napoca, Romania
[11] Univ Cattolica Sacro Cuore, Dept Radiol & Hematol Sci, Sect Radiol, Rome, Italy
[12] Fdn Policlin Univ A Gemelli IRCCS, Dept Diagnost Imaging Oncol Radiotherapy & Hemato, Rome, Italy
[13] Univ Florence, Dept Stat Comp Sci Applicat, Florence, Italy
[14] Univ Modena & Reggio Emilia, Azienda Osped Univ Modena, Dept Med & Surg Sci Children & Adults, Scleroderma Unit,Rheumatol Unit, Modena, Italy
[15] Univ Campania L Vanvitelli, Dept Med Precis, Naples, Italy
[16] Univ Florence, Careggi Univ Hosp, Dept Expt & Clin Biomed Sci, Radiodiagnost Unit 2, Florence, Italy
[17] Med Univ Graz, Dept Internal Med, Div Pulmonol, Graz, Austria
[18] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis UnIRAR, Milan, Italy
关键词
systemic sclerosis; interstitial lung disease; lung vessels; PULMONARY ARTERIAL-HYPERTENSION; PATHOGENESIS;
D O I
10.1093/rheumatology/keac311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives It has recently become possible to assess lung vascular and parenchymal changes quantitatively in thoracic CT images using automated software tools. We investigated the vessel parameters of patients with SSc, quantified by CT imaging, and correlated them with interstitial lung disease (ILD) features. Methods SSc patients undergoing standard of care pulmonary function testing and CT evaluation were retrospectively evaluated. CT images were analysed for ILD patterns and total pulmonary vascular volume (PVV) extents with Imbio lung texture analysis. Vascular analysis (volumes, numbers and densities of vessels, separating arteries and veins) was performed with an in-house developed software. A threshold of 5% ILD extent was chosen to define the presence of ILD, and commonly used cut-offs of lung function were adopted. Results A total of 79 patients [52 women, 40 ILD, mean age 56.2 (s.d. 14.2) years, total ILD extent 9.5 (10.7)%, PVV/lung volume % 2.8%] were enrolled. Vascular parameters for total and separated PVV significantly correlated with functional parameters and ILD pattern extents. SSc-associated ILD (SSc-ILD) patients presented with an increased number and volume of arterial vessels, in particular those between 2 and 4 mm of diameter, and with a higher density of arteries and veins of <6 mm in diameter. Considering radiological and functional criteria concomitantly, as well as the descriptive trends from the longitudinal evaluations, the normalized PVVs, vessel numbers and densities increased progressively with the increase/worsening of ILD extent and functional impairment. Conclusion In SSc patients CT vessel parameters increase in parallel with ILD extent and functional impairment, and may represent a biomarker of SSc-ILD severity.
引用
收藏
页码:696 / 706
页数:11
相关论文
共 50 条
  • [21] The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-Associated Interstitial Lung Disease
    Martin-Lopez, Maria
    Carreira, Patricia E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [22] The role of antifibrotic therapies in the treatment of systemic sclerosis-associated interstitial lung disease
    Boleto, Goncalo
    Avouac, Jerome
    Allanore, Yannick
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [23] Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung disease
    Pan, Jie
    Dong, Fei
    Ma, Li
    Zhao, Cheng
    Qin, Fang
    Wen, Jing
    Wei, Wanling
    Lei, Ling
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2023, 8 (03) : 231 - 240
  • [24] Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease
    Makol, Ashima
    Nagaraja, Vivek
    Amadi, Chiemezie
    Pugashetti, Janelle Vu
    Caoili, Elaine
    Khanna, Dinesh
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (06) : 613 - 626
  • [25] A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease
    Okamoto, Masaki
    Fujimoto, Kiminori
    Sadohara, Junko
    Furuya, Kiyomi
    Kaieda, Shinjiro
    Miyamura, Tomoya
    Suematsu, Eiichi
    Kitasato, Yasuhiko
    Kawayama, Tomotaka
    Ida, Hiroaki
    Ichiki, Masao
    Hoshino, Tomoaki
    RESPIRATORY INVESTIGATION, 2016, 54 (06) : 445 - 453
  • [26] Association of Computed Tomography Densitometry with Disease Severity, Functional Decline, and Survival in Systemic Sclerosis-associated Interstitial Lung Disease
    Castillo Saldana, Daniela
    Hague, Cameron J.
    Murphy, Darra
    Coxson, Harvey O.
    Tschirren, Juerg
    Peterson, Sam
    Sieren, Jered P.
    Kirby, Miranda
    Ryerson, Christopher J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (07) : 813 - 820
  • [27] The hidden costs of living with systemic sclerosis-associated interstitial lung disease
    Parfrey, Helen
    RESPIROLOGY, 2022, 27 (07) : 486 - 487
  • [28] Treatment of systemic sclerosis-associated interstitial lung disease: Lessons from clinical trials
    Roofeh, David
    Distler, Oliver
    Allanore, Yannick
    Denton, Christopher P.
    Khanna, Dinesh
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (2_SUPPL) : 61 - 71
  • [29] Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease
    Takei, Reoto
    Arita, Machiko
    Kumagai, Shogo
    Ito, Yuhei
    Tokioka, Fumiaki
    Koyama, Takashi
    Saito, Rintaro
    Nishimura, Keisuke
    Tokumasu, Hironobu
    Ishida, Tadashi
    RESPIROLOGY, 2018, 23 (04) : 385 - 391
  • [30] Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease
    Atanelishvili, I.
    Akter, T.
    Noguchi, A.
    Vuyiv, O.
    Wollin, L.
    Silver, R. M.
    Bogatkevich, G. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (04) : S115 - S124